Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |